Jan van de Winkel to deliver the Utrecht Science Lecture during the opening of Utrecht Science Week 2025
We are thrilled to announce that Prof. Dr. Jan van de Winkel, President & CEO of Genmab, will present the keynote opening Utrecht Science Lecture during the 2025 Utrecht Science Week on September 26. As a pioneering scientist and industry leader in antibody-based therapies, Jan van de Winkel has been at the forefront of groundbreaking advancements in immunotherapy, shaping the future of cancer treatment and beyond.
With more than 30 years of experience in therapeutic antibodies, Jan van de Winkel has played a pivotal role in translating cutting-edge science into life-changing medicines. As a co-founder of Genmab, he has led the company’s journey from an ambitious startup to a global end-to-end biotech powerhouse. In addition to his executive role, he holds a professorship in immunotherapy at Utrecht University, contributing to academic research and fostering the next generation of scientific leaders.
In his lecture, titled “Cracking the Code on Cancer and Other Serious Diseases: The Past, Present, and Future of Immunotherapy”, he will explore how immunotherapy is revolutionizing medicine. From early discoveries to today’s breakthroughs in cancer care, he will offer insights into the evolving role of antibody therapies, the next frontiers in biotechnology, and the power of collaboration and AI in driving innovation.
As Utrecht Science Week celebrates its fifth edition, this keynote lecture will highlight Utrecht’s ambition as the “Heart of Health” and the Utrecht Science Park as a unique life sciences ecosystem for cutting-edge research and medical innovation. Join us to gain a front-row perspective on the future of immunotherapy and how partnerships between academia, industry, and healthcare can accelerate progress for patients worldwide.
You can register here.
ZonMw grants for group leaders Den Hertog, Mattiroli, Bakkers and Van Rooij
Jeroen den Hertog, Francesca Mattiroli, Jeroen Bakkers, and Eva van Rooij, group leaders at the Hubrecht Institute, have received ZonMw Open Competition grants. The grants allow them to delve deeper into their research on RASopathies and heart regeneration. You can learn more about their projects below.
Jeroen Kingma to be the new Director of Campus & Facilities
As of 1 April 2026, Jeroen Kingma will be the new Director of the Campus & Facilities. In this role, he will lead the Campus & Facilities department and will be responsible for policy and implementation in the areas of real estate, accommodation and facility services. Kingma currently serves as Vice Chair of the Supervisory Board at Zorggroep Tangenborgh.
Utrecht Science Park Foundation is looking for a new Director-Executive
The current Director-Executive, Jan Henk van der Velden of the Utrecht Science Park Foundation, has announced that he will step down from his role as of July 1, 2026. In the coming period, a search will be conducted for an enthusiastic successor.
UtrechtInc has been recognized in the Financial Times “Europe’s Leading Startup Hubs 2026” ranking.
While UtrechtInc is proud of this recognition, the real stars of the story are the entrepreneurs, researchers, and students who walk through its doors every day.